Breaking News Instant updates and real-time market news.

HIPO

Hippo

/

+

16:14
08/11/22
08/11
16:14
08/11/22
16:14

Hippo reports Q2 EPS (13c), consensus (11c)

Reports Q2 revenue $29M, consensus $29.74M. "We closed the first half of 2022 in a strong position with continued growth, geographic expansion and Gross Loss Ratio improvement," said Hippo President and CEO Rick McCathron. "Our target markets are responding positively to our proactive approach to home protection, and we are proud to improve our full year guidance for Gross Loss Ratio from 100% to below 90% as we work to accelerate our timeline to profitability."

  • 11

    Aug

  • 31

    Aug

OTHER BREAKING NEWS FROM THE FLY

Initiation
Sinch initiated with an Equal Weight at Morgan Stanley » 04:49
09/29/22
09/29
04:49
09/29/22
04:49
CLCMF

Sinch

$1.75 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLCMF Sinch
$1.75 /

+ (+0.00%)

CLCMF Sinch
$1.75 /

+ (+0.00%)

07/12/22 Goldman Sachs
Sinch downgraded to Neutral from Buy at Goldman Sachs
03/22/22 Berenberg
Sinch initiated with a Buy at Berenberg
01/10/22 Goldman Sachs
Sinch initiated with a Buy at Goldman Sachs
Downgrade
Hugo Boss downgraded to Reduce from Add at Baader Helvea » 04:47
09/29/22
09/29
04:47
09/29/22
04:47
BOSSY

Hugo Boss

$9.25 /

-0.12 (-1.28%)

Baader Helvea analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BOSSY Hugo Boss
$9.25 /

-0.12 (-1.28%)

09/27/22 Deutsche Bank
Hugo Boss downgraded to Hold from Buy at Deutsche Bank
08/04/22 JPMorgan
Hugo Boss price target raised to EUR 68 from EUR 64 at JPMorgan
08/04/22 DZ Bank
Hugo Boss downgraded to Hold from Buy at DZ Bank
07/19/22 RBC Capital
Hugo Boss price target raised to EUR 64 from EUR 61 at RBC Capital
BOSSY Hugo Boss
$9.25 /

-0.12 (-1.28%)

Initiation
Getty Images initiated with a Neutral at Goldman Sachs » 04:46
09/29/22
09/29
04:46
09/29/22
04:46
GETY

Getty Images

$7.63 /

-0.29 (-3.66%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GETY Getty Images
$7.63 /

-0.29 (-3.66%)

GETY Getty Images
$7.63 /

-0.29 (-3.66%)

09/20/22 Macquarie
Macquarie starts Getty at Neutral, sees near-term risk as shares come to market
09/20/22 Macquarie
Getty Images initiated with a Neutral at Macquarie
08/25/22 Redburn
Redburn starts Shutterstock with Buy, Getty Images with Neutral
08/25/22 Redburn
Getty Images initiated with a Neutral at Redburn
GETY Getty Images
$7.63 /

-0.29 (-3.66%)

GETY Getty Images
$7.63 /

-0.29 (-3.66%)

General news
European stock markets are selling off again » 04:45
09/29/22
09/29
04:45
09/29/22
04:45
$ECON

Economic Data

/

+

European stock markets…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Recommendations
Banco Bradesco price target raised to $5.40 from $4.40 at Goldman Sachs » 04:44
09/29/22
09/29
04:44
09/29/22
04:44
BBD

Banco Bradesco

$3.67 /

-0.005 (-0.14%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BBD Banco Bradesco
$3.67 /

-0.005 (-0.14%)

08/29/22 Grupo Santander
Banco Bradesco downgraded to Neutral from Outperform at Grupo Santander
01/24/22 Barclays
Banco Bradesco initiated with an Overweight at Barclays
BBD Banco Bradesco
$3.67 /

-0.005 (-0.14%)

Recommendations
Santander Brasil price target raised to $6.70 from $6.20 at Goldman Sachs » 04:43
09/29/22
09/29
04:43
09/29/22
04:43
BSBR

Santander Brasil

$5.64 /

+0.02 (+0.36%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BSBR Santander Brasil
$5.64 /

+0.02 (+0.36%)

07/27/22 Barclays
Santander Brasil price target lowered to $6 from $7 at Barclays
04/28/22 Itau BBA
Santander Brasil downgraded to Underperform from Market Perform at Itau BBA
01/24/22 Barclays
Santander Brasil initiated with an Equal Weight at Barclays
01/13/22 Goldman Sachs
Santander Brasil upgraded to Neutral from Sell at Goldman Sachs
Upgrade
Itau Unibanco upgraded to Buy from Neutral at Goldman Sachs » 04:42
09/29/22
09/29
04:42
09/29/22
04:42
ITUB

Itau Unibanco

$5.12 /

+ (+0.00%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ITUB Itau Unibanco
$5.12 /

+ (+0.00%)

ITUB Itau Unibanco
$5.12 /

+ (+0.00%)

08/29/22 Grupo Santander
Itau Unibanco downgraded to Neutral from Outperform at Grupo Santander
02/11/22 JPMorgan
Itau Unibanco upgraded to Overweight from Neutral at JPMorgan
01/24/22 Barclays
Itau Unibanco initiated with an Equal Weight at Barclays
ITUB Itau Unibanco
$5.12 /

+ (+0.00%)

Downgrade
BB Seguridade downgraded to Neutral from Buy at Goldman Sachs » 04:39
09/29/22
09/29
04:39
09/29/22
04:39
BBSEY

BB Seguridade

$5.12 /

-0.165 (-3.13%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BBSEY BB Seguridade
$5.12 /

-0.165 (-3.13%)

07/15/22 JPMorgan
BB Seguridade upgraded to Overweight from Neutral at JPMorgan
06/28/22 Itau BBA
BB Seguridade upgraded to Outperform from Market Perform at Itau BBA
Conference/Events
EDAP TMS to hold an expert panel » 23:57
09/28/22
09/28
23:57
09/28/22
23:57
EDAP

EDAP TMS

$8.08 /

+0.08 (+1.00%)

CEO Oczachowski hosts an…

CEO Oczachowski hosts an Urology Expert Panel and live Focal One technology demonstration in New York on September 29 at 8 am. Webcast Link

ShowHide Related Items >><<
EDAP EDAP TMS
$8.08 /

+0.08 (+1.00%)

EDAP EDAP TMS
$8.08 /

+0.08 (+1.00%)

05/18/22 Piper Sandler
EDAP TMS price target lowered to $11 from $13 at Piper Sandler
11/19/21 B. Riley
EDAP TMS price target lowered to $10 from $13 at B. Riley
EDAP EDAP TMS
$8.08 /

+0.08 (+1.00%)

  • 23
    Sep
EDAP EDAP TMS
$8.08 /

+0.08 (+1.00%)

Conference/Events
Vulcan Materials to hold virtual investor day » 23:47
09/28/22
09/28
23:47
09/28/22
23:47
VMC

Vulcan Materials

$156.15 /

+3.91 (+2.57%)

Virtual Investor Day to…

Virtual Investor Day to be held on September 29 at 8 am. Webcast Link

ShowHide Related Items >><<
VMC Vulcan Materials
$156.15 /

+3.91 (+2.57%)

VMC Vulcan Materials
$156.15 /

+3.91 (+2.57%)

09/22/22 JPMorgan
Vulcan Materials price target raised to $185 from $170 at JPMorgan
09/21/22 Barclays
Barclays sees over 45% potential upside in Vulcan shares
09/01/22 Vertical Research
Vulcan Materials upgraded to Buy from Hold at Vertical Research
08/18/22 Raymond James
Vulcan Materials assumed with Outperform from Market Perform at Raymond James
VMC Vulcan Materials
$156.15 /

+3.91 (+2.57%)

VMC Vulcan Materials
$156.15 /

+3.91 (+2.57%)

Hot Stocks
Guidewire announces $200M accelerated share buyback program » 20:28
09/28/22
09/28
20:28
09/28/22
20:28
GWRE

Guidewire

$61.98 /

+0.24 (+0.39%)

Guidewire "announced…

Guidewire "announced that as part of its previously announced $400M share repurchase authorization, the company has entered into an accelerated share repurchase agreement with Morgan Stanley & Co. LLC to repurchase an aggregate of $200M of Guidewire's outstanding shares of common stock."

ShowHide Related Items >><<
GWRE Guidewire
$61.98 /

+0.24 (+0.39%)

GWRE Guidewire
$61.98 /

+0.24 (+0.39%)

09/12/22 Citi
Guidewire price target lowered to $79 from $88 at Citi
09/08/22 Baird
Guidewire price target lowered to $81 from $99 at Baird
09/07/22 JMP Securities
Guidewire price target lowered to $95 from $110 at JMP Securities
09/07/22 RBC Capital
Guidewire price target lowered to $100 from $125 at RBC Capital
GWRE Guidewire
$61.98 /

+0.24 (+0.39%)

GWRE Guidewire
$61.98 /

+0.24 (+0.39%)

Initiation
Kindred Group initiated with a Hold at Jefferies » 19:28
09/28/22
09/28
19:28
09/28/22
19:28
KNDGF

Kindred Group

$5.20 /

-2.8 (-35.00%)

Jefferies analyst James…

Jefferies analyst James Wheatcroft initiated coverage of Kindred Group with a Hold rating and SEK 90 price target as part of a broader research note on Europe Gaming. The analyst states that the temporary exit from the Netherlands and tough comps should subdue the stock for some time, and he recommends a neutral stance given limited catalysts in the short to medium term.

ShowHide Related Items >><<
KNDGF Kindred Group
$5.20 /

-2.8 (-35.00%)

KNDGF Kindred Group
$5.20 /

-2.8 (-35.00%)

08/09/22 BofA
Kindred Group initiated with Underperform, SEK 88 target at BofA
08/09/22 BofA
Kindred Group initiated with an Underperform at BofA
07/28/22 Berenberg
Kindred Group price target lowered to SEK 113 from SEK 123 at Berenberg
04/29/22 Deutsche Bank
Kindred Group price target lowered to SEK 123 from SEK 127 at Deutsche Bank
Initiation
Kambi Group initiated with a Buy at Jefferies » 19:25
09/28/22
09/28
19:25
09/28/22
19:25
KMBIF

Kambi Group

$14.73 /

+ (+0.00%)

Jefferies analyst James…

Jefferies analyst James Wheatcroft initiated coverage of Kambi Group with a Buy rating and SEK 220 price target as part of a broader research note on Europe Gaming. The analyst cites the company's 20% share in the burgeoning U.S. sports betting market, also citing catalysts for Kambi over the next year that include a re-rating as material new contracts further endorse its proof of concept as well as an "earnings progression derived from contract renewals".

ShowHide Related Items >><<
KMBIF Kambi Group
$14.73 /

+ (+0.00%)

04/14/22 Pareto
Kambi Group downgraded to Hold from Buy at Pareto
01/07/22 Berenberg
Kambi Group initiated with a Buy at Berenberg
01/07/22 Berenberg
Kambi Group initiated with a Buy at Berenberg
Initiation
Evolution AB initiated with a Buy at Jefferies » 19:23
09/28/22
09/28
19:23
09/28/22
19:23
EVVTY

Evolution AB

$82.30 /

+3.31 (+4.19%)

Jefferies analyst James…

Jefferies analyst James Wheatcroft initiated coverage of Evolution AB with a Buy rating and SEK 1,260 price target as part of a broader research note on Europe Gaming. The analyst contends that only 50% of the live casino opportunity is currently priced in for Evolution, also noting that the stock's current valuation multiples are low versus history. Wheatcroft further states that best on its cash reserve, further buybacks and M&A are possible for the company.

ShowHide Related Items >><<
EVVTY Evolution AB
$82.30 /

+3.31 (+4.19%)

08/08/22 Deutsche Bank
Evolution AB price target lowered to SEK 1,005 from SEK 1,175 at Deutsche Bank
07/28/22 Berenberg
Evolution AB price target lowered to SEK 1,170 from SEK 1,230 at Berenberg
04/29/22 Morgan Stanley
Evolution AB price target raised to SEK 1,780 from SEK 1,750 at Morgan Stanley
04/29/22 Deutsche Bank
Evolution AB price target lowered to SEK 1,175 from SEK 1,220 at Deutsche Bank
Hot Stocks
Avita Medical names James Corbett CEO » 19:09
09/28/22
09/28
19:09
09/28/22
19:09
RCEL

Avita Medical

$5.65 /

+0.39 (+7.41%)

Avita Medical announced…

Avita Medical announced the appointment of James Corbett as Chief Executive Officer, effective immediately. Corbett, who has served as a non-executive member of the Board of Directors, will continue as an executive member of the Board of Directors of AVITA Medical, Inc. Corbett, has nearly 40 years of experience in the Life Sciences field, having served as CEO of multiple publicly traded companies, including: Microtherapeutics Inc., ev3 Inc and Alphatec Spine. "Jim is an experienced strategist with significant commercial expertise that positions him well to lead AVITA Medical through its next stage of growth and beyond," said Lou Panaccio, Chairman of the Board of AVITA Medical. "Having run a thorough process utilizing a leading executive search firm, I am confident that Jim is the right leader for the Company at this time." Corbett will succeed Dr. Michael Perry, who has served as Executive Director and Chief Executive Officer of the Company since June 2017.

ShowHide Related Items >><<
RCEL Avita Medical
$5.65 /

+0.39 (+7.41%)

RCEL Avita Medical
$5.65 /

+0.39 (+7.41%)

09/12/22 Piper Sandler
Avita Medical data for stable vitiligo treatment excellent, says Piper Sandler
03/01/22 BTIG
Avita Medical price target lowered to $21 from $37 at BTIG
03/01/22 Piper Sandler
Avita Medical price target lowered to $15 from $23 at Piper Sandler
RCEL Avita Medical
$5.65 /

+0.39 (+7.41%)

Periodicals
BP lays off most contractors at Toledo plant after fire, Reuters says » 18:53
09/28/22
09/28
18:53
09/28/22
18:53
BP

BP

$28.57 /

+1.005 (+3.65%)

, CVE

Cenovus Energy

$15.61 /

+0.77 (+5.19%)

BP (BP) laid off most…

BP (BP) laid off most contractors at its Toledo, Ohio refinery that it operates jointly with Cenovus Energy (CVE), suggesting that the facility will see a prolonged shutdown following last week's fire, Reuters' Laura Sanicola reports, citing sources familiar with the matter. The explosion at the plant killed two steelworkers, the author notes. Reference Link

ShowHide Related Items >><<
CVE Cenovus Energy
$15.61 /

+0.77 (+5.19%)

BP BP
$28.57 /

+1.005 (+3.65%)

BP BP
$28.57 /

+1.005 (+3.65%)

09/26/22 JPMorgan
BP downgraded to Neutral from Overweight at JPMorgan
09/12/22 Piper Sandler
BP price target raised to $47 from $44 at Piper Sandler
08/17/22 Morgan Stanley
BP price target raised to 566 GBp from 540 GBp at Morgan Stanley
08/08/22 Berenberg
BP price target lowered to 500 GBp from 510 GBp at Berenberg
CVE Cenovus Energy
$15.61 /

+0.77 (+5.19%)

08/10/22 Credit Suisse
Cenovus Energy assumed with an Outperform at Credit Suisse
07/18/22 National Bank
Cenovus Energy price target lowered to C$38 from C$41 at National Bank
06/16/22 National Bank
Cenovus Energy price target raised to C$41 from C$35 at National Bank
06/09/22 Credit Suisse
Cenovus Energy price target raised to C$37 from C$32 at Credit Suisse
CVE Cenovus Energy
$15.61 /

+0.77 (+5.19%)

BP BP
$28.57 /

+1.005 (+3.65%)

BP BP
$28.57 /

+1.005 (+3.65%)

BP BP
$28.57 /

+1.005 (+3.65%)

CVE Cenovus Energy
$15.61 /

+0.77 (+5.19%)

BP BP
$28.57 /

+1.005 (+3.65%)

Hot Stocks
Paychex CEO: We had record breaking sales in Q1 » 18:46
09/28/22
09/28
18:46
09/28/22
18:46
PAYX

Paychex

$117.29 /

+4.01 (+3.54%)

In an interview on…

In an interview on CNBC's Mad Money, Martin Mucci said revenue retention is better than pre-pandemic. "We're not seeing a recession at at this point," he added.

ShowHide Related Items >><<
PAYX Paychex
$117.29 /

+4.01 (+3.54%)

PAYX Paychex
$117.29 /

+4.01 (+3.54%)

07/07/22 Citi
Paychex price target lowered to $125 from $145 at Citi
06/30/22 Baird
Paychex price target lowered to $130 from $142 at Baird
06/30/22 Morgan Stanley
Paychex price target lowered to $130 from $140 at Morgan Stanley
06/30/22 Cowen
Paychex price target lowered to $135 from $140 at Cowen
PAYX Paychex
$117.29 /

+4.01 (+3.54%)

PAYX Paychex
$117.29 /

+4.01 (+3.54%)

Periodicals
McDonald's owners group says company denied request for changes, CNBC says » 18:42
09/28/22
09/28
18:42
09/28/22
18:42
MCD

McDonald's

$236.93 /

+0.19 (+0.08%)

The National Franchisee…

The National Franchisee Leadership Alliance, a group that represents McDonald's owners, said that the fast food giant spurned its request to delay changes to franchising policies, including updated standards and changes to how the company evaluates possible new operators, CNBC's Kate Rogers reports, citing a letter from the alliance to owners. The letter said that McDonald's had rejected its request to make the adjustments in June 2023 instead of January 1, the author notes. Reference Link

ShowHide Related Items >><<
MCD McDonald's
$236.93 /

+0.19 (+0.08%)

MCD McDonald's
$236.93 /

+0.19 (+0.08%)

09/27/22 Citi
Citi cuts McDonald's target, opens 'negative catalyst watch'
09/22/22 Stephens
McDonald's initiated with an Overweight at Stephens
09/21/22 Piper Sandler
Piper says Beyond Meat retail declines accelerating, cuts price target
09/07/22 Bernstein
McDonald's started at Market Perform on limited upside at Bernstein
MCD McDonald's
$236.93 /

+0.19 (+0.08%)

MCD McDonald's
$236.93 /

+0.19 (+0.08%)

MCD McDonald's
$236.93 /

+0.19 (+0.08%)

MCD McDonald's
$236.93 /

+0.19 (+0.08%)

Syndicate
Valneva announces global offering for about $40M in ADS » 18:41
09/28/22
09/28
18:41
09/28/22
18:41
VALN

Valneva

$11.11 /

+0.11 (+1.00%)

Goldman Sachs, Jefferies,…

Goldman Sachs, Jefferies, Guggenheim, and Bryan, Garnier & Co. acted as joint book running managers for the offering.

ShowHide Related Items >><<
VALN Valneva
$11.11 /

+0.11 (+1.00%)

VALN Valneva
$11.11 /

+0.11 (+1.00%)

09/23/22 Goldman Sachs
Valneva downgraded to Neutral from Buy at Goldman Sachs
08/19/22 H.C. Wainwright
Valneva price target lowered to $32 from $34 at H.C. Wainwright
08/03/22 H.C. Wainwright
Valneva initiated with a Buy at H.C. Wainwright
07/28/22 Kepler Cheuvreux
Valneva downgraded on lower COVID vaccine orders at Kepler Cheuvreux
  • 29
    Oct
VALN Valneva
$11.11 /

+0.11 (+1.00%)

Conference/Events
Kura Oncology management to meet with Cantor Fitzgerald » 18:25
09/28/22
09/28
18:25
09/28/22
18:25
KURA

Kura Oncology

$13.42 /

+0.71 (+5.59%)

In conjunction with the…

In conjunction with the Cantor Oncology, Hematology & HemeOnc Conference, Cantor Fitzgerald Biotechnology Analyst Watsek holds an Investor Group Dinner with President & CEO Wilson and SVP DeSpain in New York on September 28 at 6:30 pm hosted by Cantor Fitzgerald.

ShowHide Related Items >><<
KURA Kura Oncology
$13.42 /

+0.71 (+5.59%)

KURA Kura Oncology
$13.42 /

+0.71 (+5.59%)

07/12/22 Cantor Fitzgerald
Kura Oncology initiated with an Overweight at Cantor Fitzgerald
07/12/22 Cantor Fitzgerald
Kura Oncology initiated with an Overweight at Cantor Fitzgerald
02/15/22 Jefferies
Kura Oncology initiated with a Buy at Jefferies
11/26/21 Credit Suisse
Kura Oncology price target lowered to $21 from $40 at Credit Suisse
KURA Kura Oncology
$13.42 /

+0.71 (+5.59%)

KURA Kura Oncology
$13.42 /

+0.71 (+5.59%)

Hot Stocks
Amazon.com expands pay, benefits for U.S. front-line employees » 18:22
09/28/22
09/28
18:22
09/28/22
18:22
AMZN

Amazon.com

$117.95 /

+3.53 (+3.09%)

Amazon announced pay…

Amazon announced pay increases for its U.S. front-line employees, a nearly $1B investment over the next year, along with a new benefit that enables employees to collect their pay at any point during the month. Average starting pay for front-line employees in customer fulfillment and transportation is increasing from $18 per hour to more than $19 per hour, with employees earning between $16 and $26 per hour depending on their position and location in the U.S. The company also announced additional investments in career development programs, building on its commitment to provide free college tuition to hourly employees. This brings the company's total investment in benefits offered to its team to nearly $10B this year alone. To prioritize flexibility and make access to pay as easy, instant, and convenient as possible for employees, Amazon expanded its pay access program, Anytime Pay, to all employees across its U.S. operations, corporate and technology networks. Anytime Pay provides Amazon employees access to up to 70% of their eligible earned pay-whenever they choose and without fees-with the goal of putting employees in control of their pay schedule. Previously, most Amazon employees received their regular pay once or twice monthly. Anytime Pay now offers employees access to their earned pay as often as they like. Building on the commitment to create career advancement opportunities for 300,000 employees through 2025, Amazon has formally added an additional development program, Amazon Intelligence Initiative. This career advancement program is designed to place employees in engineering roles within Amazon Web Services, working to operate AWS's Dedicated Cloud regions. Employees participate in a 12- to 14-month development program to enhance their technical skills. These engineers then complete multiple on the job rotations with hands-on experience alongside top AWS engineers. The Amazon Intelligence Initiative provides participants with full-time employment during this training, with great pay and benefits. Once their time in the program is completed, employees are placed into the most appropriate roles.

ShowHide Related Items >><<
AMZN Amazon.com
$117.95 /

+3.53 (+3.09%)

AMZN Amazon.com
$117.95 /

+3.53 (+3.09%)

09/28/22 Truist
Truist starts 'diversified mobility powerhouse' Rivian Automotive at Buy
09/28/22 Truist
Amazon.com price target lowered to $170 from $180 at Truist
09/26/22 Canaccord
Pay with Venmo launch on Amazon next catalyst for PayPal, says Canaccord
09/22/22 Northland
Amazon TNF kickoff scores 'a win' for Edgio, says Northland
AMZN Amazon.com
$117.95 /

+3.53 (+3.09%)

AMZN Amazon.com
$117.95 /

+3.53 (+3.09%)

AMZN Amazon.com
$117.95 /

+3.53 (+3.09%)

AMZN Amazon.com
$117.95 /

+3.53 (+3.09%)

Downgrade
Applied Genetic downgraded to Neutral from Buy at BTIG » 18:22
09/28/22
09/28
18:22
09/28/22
18:22
AGTC

Applied Genetic

/

+

, BIIB

Biogen

$276.59 /

+78.74 (+39.80%)

BTIG analyst Yun Zhong…

BTIG analyst Yun Zhong downgraded Applied Genetic (AGTC) to Neutral from Buy. The company has reported a stronger dataset than competitors that are developing similar AAV gene therapy programs for the same indication, and the stock is trading below cash with approximately 67.6M shares outstanding as of September 21, the analyst tells investors in a research note, also noting that Biogen's (BIIB) Alzheimer's disease data yesterday provided a strong lift for the entire biotech sector. Zhong adds however that the significant uncertainty created by the cash overhang for Applied Genetic, which has only $67.8M as of the end of Q3, suggests that a more prudent approach should be to remove the AGTC-501 program from valuation at this moment.

ShowHide Related Items >><<
BIIB Biogen
$276.59 /

+78.74 (+39.80%)

AGTC Applied Genetic
/

+

AGTC Applied Genetic
/

+

09/28/22 Chardan
Applied Genetic price target lowered to $3 from $5 at Chardan
06/28/22 H.C. Wainwright
H.C. Wainwright says Applied's AGTC-501 'remains leader' after MeiraGTx data
03/29/22 Chardan
Applied Genetic transferred with Buy rating at Chardan
02/14/22 Stifel
Stifel keeps Buy rating on Applied Genetic, lowers price target to $10
BIIB Biogen
$276.59 /

+78.74 (+39.80%)

09/28/22 Morgan Stanley
Eisai upgraded to Equal Weight at Morgan Stanley after lecanemab success
09/28/22 BofA
Prothena upgraded at BofA as Biogen data seen strengthening amyloid thesis
09/28/22 Needham
Path for Biogen's lecanemab to be 'multi-step' process, says Needham
09/28/22 RBC Capital
Biogen price target raised to $321 from $251 at RBC Capital
BIIB Biogen
$276.59 /

+78.74 (+39.80%)

  • 14
    Jul
  • 22
    Mar
BIIB Biogen
$276.59 /

+78.74 (+39.80%)

AGTC Applied Genetic
/

+

BIIB Biogen
$276.59 /

+78.74 (+39.80%)

Syndicate
Voxeljet announces proposed offering of ordinary shares » 18:16
09/28/22
09/28
18:16
09/28/22
18:16
VJET

Voxeljet

$3.85 /

+0.23 (+6.35%)

Voxeljet management board…

Voxeljet management board approved, with the consent of the supervisory board, an increase in the company's registered share capital against cash contributions, under exclusion of the subscription rights of existing shareholders, in an amount of up to EUR 2,108,013.00. In conjunction with the capital increase, the company will issue new registered ordinary shares with dividend entitlements beginning for the 2022 financial year, which will be offered in the form of American Depositary Receipts. Each ADR represents one ordinary share. The placement will take place today. The ADRs are listed on NASDAQ. A.G.P./Alliance Global Partners is acting as sole placement agent for the offering.

ShowHide Related Items >><<
VJET Voxeljet
$3.85 /

+0.23 (+6.35%)

VJET Voxeljet
$3.85 /

+0.23 (+6.35%)

08/19/22 Alliance Global Partners
Voxeljet price target raised to $10 from $9 at Alliance Global Partners
05/20/22 Alliance Global Partners
Voxeljet price target lowered to $9 from $15 at Alliance Global Partners
11/12/21 Alliance Global Partners
Voxeljet price target lowered to $15 from $22 at Alliance Global Partners
VJET Voxeljet
$3.85 /

+0.23 (+6.35%)

VJET Voxeljet
$3.85 /

+0.23 (+6.35%)

Hot Stocks
Vail Resorts sees FY23 reported EBITDA $890M-$950M vs. $833M in FY22 » 18:04
09/28/22
09/28
18:04
09/28/22
18:04
MTN

Vail Resorts

$209.78 /

+6.13 (+3.01%)

Sees FY23 net income…

Sees FY23 net income $321M-$396M vs. $347.9M in FY22. The company states: "As we head into fiscal year 2023, we are encouraged by the strength in advance commitment product sales and our continued focus on enhancing the guest and employee experience while maintaining cost discipline. Our employee investment of approximately $175 million to return to full staffing levels and operational footprints, along with our expected capital investment of over $300 million in calendar year 2022, are expected to further elevate the guest experience this season and increase the capacity of our resorts. Despite facing broad cost inflation and after incorporating our industry-leading wage investment, we expect meaningful growth for fiscal 2023 relative to fiscal 2022 and strong Resort EBITDA margin. Our guidance for net income attributable to Vail Resorts, Inc. is estimated to be between $321 million and $396 million for fiscal 2023. We estimate Resort Reported EBITDA for fiscal 2023 will be between $893 million and $947 million. We expect the operations of the Seven Springs Resorts and Andermatt-Sedrun to contribute approximately $22 million of Resort Reported EBITDA in fiscal year 2023, which is an incremental $4 million of Resort Reported EBITDA compared to fiscal year 2022, excluding acquisition and integration related expenses. Acquisition and integration related expenses are expected to be an estimated $4 million in fiscal year 2023 associated with the resort acquisitions. We estimate Resort EBITDA Margin for fiscal 2023 to be approximately 31.0% using the midpoint of the guidance range."

ShowHide Related Items >><<
MTN Vail Resorts
$209.78 /

+6.13 (+3.01%)

MTN Vail Resorts
$209.78 /

+6.13 (+3.01%)

09/26/22 Stifel
Vail Resorts price target lowered to $228 from $273 at Stifel
06/28/22 Barclays
Barclays says shift in preferences to cushion Gaming, Cruises, Timeshare names
06/28/22 Barclays
Vail Resorts initiated with an Underweight at Barclays
06/10/22 Truist
Vail Resorts price target raised to $281 from $278 at Truist
MTN Vail Resorts
$209.78 /

+6.13 (+3.01%)

MTN Vail Resorts
$209.78 /

+6.13 (+3.01%)

Earnings
Enerpac Tool sees FY23 revenue $565M-$585M, consensus $597.8M » 18:03
09/28/22
09/28
18:03
09/28/22
18:03
EPAC

Enerpac Tool

$16.83 /

+0.57 (+3.51%)

Sees FY23 adjusted EBITDA…

Sees FY23 adjusted EBITDA $113M-$123M, including an ASCEND EBITDA benefit of $12M-$18M.

ShowHide Related Items >><<
EPAC Enerpac Tool
$16.83 /

+0.57 (+3.51%)

EPAC Enerpac Tool
$16.83 /

+0.57 (+3.51%)

06/22/22 Wells Fargo
Wells Fargo upgrades Enerpac Tool to Overweight, raises price target to $23
06/22/22 Wells Fargo
Enerpac Tool upgraded to Overweight from Equal Weight at Wells Fargo
01/07/22 JPMorgan
Enerpac Tool upgraded to Neutral at JPMorgan after underperformance
01/07/22 JPMorgan
Enerpac Tool upgraded to Neutral from Underweight at JPMorgan
EPAC Enerpac Tool
$16.83 /

+0.57 (+3.51%)

EPAC Enerpac Tool
$16.83 /

+0.57 (+3.51%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.